Want to see AXR full AI Analyst Report?
Top Page
Amrep
(NYSE:AXR)
Select Model
Select Model
Rating:62Neutral
Price Target:
$22.00
▼(-4.56% Downside)
Action:Reiterated
Date:09/12/26
The score is anchored by AXR’s very strong, low-leverage balance sheet (a major risk reducer), but is held back by weakening TTM operating trends and highly volatile cash flow. Technicals show a soft trend with limited momentum, while valuation (P/E ~20.9, no dividend yield provided) looks only fair given the recent slowdown. Corporate updates are mixed, with governance improvements offset by a notably weaker recent quarterly performance disclosure.
Positive Factors
Very Low Leverage
AMREP’s near-zero leverage materially limits financial risk and reduces the burden of interest or refinancing costs. A predominantly equity-funded balance sheet gives the company greater flexibility to withstand uneven land-sale timing and continue funding development without relying heavily on debt.
Negative Factors
Revenue and Margin Contraction
The recent top-line contraction and margin step-down weaken the quality of AMREP’s earnings trajectory. If lower transaction volume or less favorable land economics persist, reduced revenue conversion and profitability could constrain reinvestment and make future earnings less dependable.
Read all positive and negative factors
Positive Factors
Negative Factors
Very Low Leverage
AMREP’s near-zero leverage materially limits financial risk and reduces the burden of interest or refinancing costs. A predominantly equity-funded balance sheet gives the company greater flexibility to withstand uneven land-sale timing and continue funding development without relying heavily on debt.
Read all positive factors
Amrep Key Performance Indicators (KPIs)
Any
Revenue by Segment
Breaks down revenue across different business segments, showcasing which areas drive growth and profitability, and where strategic focus may be needed.
Breaks down revenue across different business segments, showcasing which areas drive growth and profitability, and where strategic focus may be needed.
Data provided by:
The Fly
The FlyAmrep (AXR) vs. SPDR S&P 500 ETF (SPY)
Market Cap
$109.64M
Dividend YieldN/A
Average Volume (3M)10.76K
Price to Earnings (P/E)18.7
Beta (1Y)0.59
Revenue Growth-15.29%
EPS Growth-56.15%
CountryUS
Employees52
SectorReal Estate
Sector Strength53
IndustryReal Estate - Development
Share Statistics
EPS (TTM)1.10
Shares Outstanding5,324,849
10 Day Avg. Volume9,135
30 Day Avg. Volume10,763
Financial Highlights & Ratios
PEG Ratio-0.74
Price to Book (P/B)1.04
Price to Sales (P/S)2.78
P/FCF Ratio11.51
Enterprise Value/Market Cap0.70
Enterprise Value/Revenue1.86
Enterprise Value/Gross Profit3.79
Enterprise Value/Ebitda9.40
Forecast
1Y Price Target
$22.00Price Target Upside-4.56% Downside
Rating ConsensusHold
Number of Analyst Covering1
EPS Forecast (FY)1.55
Revenue Forecast (FY)$51.79M
Amrep Business Overview & Revenue Model
Company Description
Established in 1961 and headquartered in Havertown, Pennsylvania, AMREP Corporation is primarily involved in the real estate industry, operating through its subsidiaries. The company's operations are divided into two main divisions: land developme...
How the Company Makes Money
AMREP primarily makes money by monetizing its land assets. The company’s main revenue stream comes from selling developed and undeveloped land, including residential lots, to homebuilders and other buyers. Revenue is recognized when control of the...
Amrep Financial Statement Overview
Summary
Income Statement
62
Positive
Balance Sheet
91
Very Positive
Cash Flow
48
Neutral
| Breakdown | TTM | Apr 2025 | Apr 2024 | Apr 2023 | Apr 2022 | Apr 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 41.05M | 52.85M | 49.69M | 51.37M | 48.68M | 62.48M |
| Gross Profit | 20.12M | 31.02M | 32.88M | 14.47M | 18.90M | 26.66M |
| EBITDA | 8.12M | 14.44M | 12.29M | 7.75M | 7.70M | 21.79M |
| Net Income | 5.87M | 10.29M | 12.72M | 6.69M | 21.79M | 15.86M |
Balance Sheet | ||||||
| Total Assets | 145.66M | 147.35M | 133.78M | 122.83M | 115.89M | 94.92M |
| Cash, Cash Equivalents and Short-Term Investments | 48.68M | 52.69M | 39.92M | 29.69M | 19.99M | 15.72M |
| Total Debt | 17.00K | 167.00K | 34.00K | 27.00K | 44.00K | 2.03M |
| Total Liabilities | 4.54M | 6.61M | 3.82M | 4.78M | 4.89M | 11.76M |
| Stockholders Equity | 141.11M | 140.74M | 129.96M | 118.05M | 111.00M | 83.16M |
Cash Flow | ||||||
| Free Cash Flow | 962.00K | 12.78M | 9.66M | 10.26M | 6.26M | 14.19M |
| Operating Cash Flow | 1.02M | 12.88M | 10.24M | 10.71M | 6.39M | 15.48M |
| Investing Cash Flow | -86.00K | -102.00K | -553.00K | -457.00K | -131.00K | -1.20M |
| Financing Cash Flow | -7.00K | -8.00K | -9.00K | -9.00K | -1.99M | -23.36M |
Amrep Technical Analysis
Negative
23.05
Price Trends
22.06
Negative
23.32
Negative
24.30
Negative
Market Momentum
-0.50
Negative
42.25
Neutral
70.68
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For AXR, the sentiment is Negative. The current price of 23.05 is above the 20-day moving average (MA) of 20.82, above the 50-day MA of 22.06, and below the 200-day MA of 24.30, indicating a bearish trend. The MACD of -0.50 indicates Negative momentum. The RSI at 42.25 is Neutral, neither overbought nor oversold. The STOCH value of 70.68 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for AXR.
Amrep Peers Comparison
UnderperformOutperform
Sector (65)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
69 Neutral | $1.33B | 7.78 | 9.42% | ― | 11.76% | 4.46% | |
65 Neutral | $2.17B | 12.19 | 3.79% | 4.94% | 3.15% | 1.96% | |
62 Neutral | $109.64M | 18.69 | 4.21% | ― | -15.29% | -56.15% | |
61 Neutral | $456.25M | 10.17 | 3.47% | ― | -39.15% | -69.83% | |
51 Neutral | $256.66M | 30.82 | 1.36% | ― | 6.77% | ― |
* Real Estate Sector Average
AXR
Amrep
20.59
-2.72
-11.67%
ARL
American Realty Investors
15.89
0.16
1.02%
FOR
Forestar Group
25.98
-1.98
-7.08%
FPH
Five Point Holdings
4.16
-1.79
-30.08%
AEI
Alset EHome International
0.59
-2.62
-81.68%
OZ
Belpointe PREP
35.52
-27.58
-43.71%
Amrep Corporate Events
Executive/Board ChangesFinancial DisclosuresShareholder Meetings
Amrep Shareholders Approve New 2026 Equity Compensation Plan
Negative
Sep 11, 2026
At AMREP’s 2026 Annual Meeting of Shareholders held on September 10, 2026, investors approved a new 2026 Equity Compensation Plan, effective September 20, 2026 and running until September 19, 2036 unless terminated earlier by the board. The ...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.